Targeting the Tumor Stroma: the Biology and Clinical Development of Pegylated Recombinant Human Hyaluronidase (PEGPH20).
Curr Oncol Rep
; 19(7): 47, 2017 Jul.
Article
en En
| MEDLINE
| ID: mdl-28589527
Palabras clave
CD44; Convection; Diffusion; Extracellular matrix; Gemcitabine; Glycosaminoglycan; Hyaluronan; Hyaluronic acid; Immunotherapy; Interstitial fluid pressure; KPC mice; Nab-paclitaxel; PEGPH20; Pancreatic ductal adenocarcinoma; Pegylated recombinant human hyaluronidase; RHAMM; Stromal resistance; Thromboembolic events; Tumor microenvironment; Tumor perfusion; Tumor stroma
Texto completo:
1
Banco de datos:
MEDLINE
Asunto principal:
Proteínas Recombinantes
/
Adenocarcinoma
/
Carcinoma Ductal Pancreático
/
Ácido Hialurónico
/
Hialuronoglucosaminidasa
Tipo de estudio:
Prognostic_studies
Límite:
Humans
Idioma:
En
Año:
2017
Tipo del documento:
Article